NYXH Nyxoah

Publication relating to transparency notifications

Publication relating to transparency notifications

                

REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), December 2, 2025, 10:30 pm CET / 4:30 pm ET In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below.

Robert Taub / BMI Estate

On November 27, 2025, Nyxoah received a transparency notification from Robert Taub and related person BMI Estate. Based on the notification, Robert Taub (together with his controlled undertakings) holds 4,290,800 voting rights, consisting of 4,240,800 voting rights linked to securities and 50,000 equivalent financial instruments, representing 9.97% of the total number of voting rights on November 20, 2025 (43,026,460).

The notification dated November 27, 2025 contains the following information:

  • Reason for the notification: passive crossing of a threshold
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Robert Taub
    • BMI Estate (with address at Avenue des Croix de Guerre 149 / 13, 1120 Brussels)
  • Date on which the threshold was crossed: November 20, 2025
  • Threshold that is crossed: 10%
  • Denominator: 43,026,460
  • Notified details:



A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities
Robert Taub2,121,4702,712,510 6.30% 
BMI Estate0567,484 1.32% 
Robelga SRL696,000960,806 2,23% 
Subtotal2,817,4704,240,800 9.86% 
 TOTAL4,240,80009.86%0.00%



B) Equivalent financial instrumentsAfter the transaction
Holders of equivalent financial instrumentsType of financial instrumentExpiration dateExercise period or date# of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement
Robert TaubWarrants08/06/2027 25,0000.06%cash
Robert TaubWarrants14/06/2028 25,0000.06%cash
 TOTAL  50,0000.12% 



 TOTAL (A & B)# of voting rights% of voting rights 
    4,290,8009.97% 
  • Full chain of controlled undertakings through which the holding is effectively held: Robelga SRL is 100% owned by BMI Estate (a partnership (société simple) without legal personality). Robert Taub has 100% usufruct and Robert Taub’s children have 100% bare ownership of BMI Estate.



Robert Taub / BMI Estate

On December 2, 2025, Nyxoah received a transparency notification from Robert Taub and related entity BMI Estate. Based on the notification, Robert Taub (together with his controlled undertakings) holds 4,360,800 voting rights, consisting of 4,310,800 voting rights linked to securities and 50,000 equivalent financial instruments, representing 10.14% of the total number of voting rights on December 1, 2025 (43,026,460).

The notification dated December 2, 2025 contains the following information:

  • Reason for the notification: acquisition or disposal of voting securities or voting rights
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Robert Taub
    • BMI Estate (with address at Avenue des Croix de Guerre 149 / 13, 1120 Brussels)
  • Date on which the threshold was crossed: December 1, 2025
  • Threshold that is crossed: 10%
  • Denominator: 43,026,460
  • Notified details:



A) Voting rightsPrevious notificationAfter the transaction
 # of voting rights# of voting rights% of voting rights
Holders of voting rights Linked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities
Robert Taub2,712,5102,712,510 6.30% 
BMI Estate567,484567,484 1.32% 
Robelga SRL960,8061,030,806 2.40% 
Subtotal4,240,8004,310,800 10.02% 
 TOTAL4,310,800010.02%0.00%



B) Equivalent financial instrumentsAfter the transaction
Holders of equivalent financial instrumentsType of financial instrumentExpiration dateExercise period or date# of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement
Robert TaubWarrants08/06/2027 25,0000.06%cash
Robert TaubWarrants14/06/2028 25,0000.06%cash
 TOTAL  50,0000.12% 



 TOTAL (A & B)# of voting rights% of voting rights 
    4,360,80010.14% 
  • Full chain of controlled undertakings through which the holding is effectively held: Robelga SRL is 100% owned by BMI Estate (a partnership (société simple) without legal personality). Robert Taub has 100% usufruct and Robert Taub’s children have 100% bare ownership of BMI Estate.



*

* *

Contact:

Nyxoah

John Landry, CFO



Attachment



EN
02/12/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE

Publication relating to transparency notifications

Publication relating to transparency notifications                  REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 2, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Robert Taub / BMI Estate On November 27, 2025, Nyxoah received a transparency notification from Robert Taub and related person BMI Estate. Based on the notifi...

 PRESS RELEASE

Publication relative à des notifications de transparence

Publication relative à des notifications de transparence          INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 2 décembre 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) annonce qu’elle a reçu deux notifications de transparence comme détaillées ci-dessous. Robert Taub / BMI Estate Le 27 novembre 2025, Nyxoah a reçu une notification de transparence de Robert Taub et d’une personne lié...

 PRESS RELEASE

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conf...

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, Dec. 4, 20...

 PRESS RELEASE

Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conferenc...

Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference Mont-Saint-Guibert, Belgique – 27 novembre 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») une société de technologie médicale spécialisée dans le développement et la commercialisation de solutions innovantes pour le traitement de l'Apnée Obstructive du Sommeil (« AOS ») par neuromodulation, a annoncé aujourd'hui que son management participera à une discussion informelle lors de la Piper S...

 PRESS RELEASE

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimburseme...

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is positive news for Nyxoah’s U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, 2025, 7:45 am CET / 1:45 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Ap...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch